Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Biogen Idec News

Biogen Idec News Newsletter

Biosimilars Market 2024-2031 Market Analysis: Growth Trends, Demand, and Forecast Overview | Biogen Idec Inc 04 Nov 2024 22:19 GMT
… AG ◘ Merck & Co. Inc. ◘ Biogen Idec Inc ◘ Coherus BioSciences ◘ Stada Arzneimittel …
Biosimilars Market Projected to Witness Huge Growth by 2024-2031 | Biogen Idec Inc, Celltrion Healthcare Co., Ltd 08 Oct 2024 11:09 GMT
… AG ◘ Merck & Co. Inc. ◘ Biogen Idec Inc ◘ Coherus BioSciences ◘ Stada Arzneimittel …
Multiple Sclerosis Therapeutics Market Expected to Expand at a Steady 2024-2031 | Bayer AG, Pfizer, Inc., Biogen Idec 10 Apr 2024 07:23 GMT
… .A. ◘ Bayer AG ◘ Pfizer Inc. ◘ Biogen Idec ◘ Merck & Co. Inc. ◘ AbbVie …
Autoinjectors Market May See a Big Move | Ypsomed, Biogen Idec, Gerresheimer 02 Feb 2024 22:13 GMT
… Medical, Teva Pharmaceutical Industries, Ypsomed, Biogen Idec, Owen Mumford, Consort Medical, AbbVie … , Teva Pharmaceutical Industries, and Ypsomed, Biogen Idec, Owen Mumford, Consort Medical, Abbvie …
Biogen Idec 28 Aug 2023 04:28 GMT
The Rise of Autoinjectors Market: Innovation in Self-Administered Therapies | Ypsomed, Biogen Idec, Abbvie, Gerresheimer 12 Jul 2023 20:58 GMT
… Medical, Teva Pharmaceutical Industries, Ypsomed, Biogen Idec, Owen Mumford, Consort Medical, Abbvie … , Teva Pharmaceutical Industries, and Ypsomed, Biogen Idec, Owen Mumford, Consort Medical, Abbvie …
<![CDATA[Kidney Compass: Obinutuzumab, REGENCY, & Updates in Lupus Nephritis, With Brad Rovin, MD]]> 08 Nov 2025 21:58 GMT
… , AstraZeneca/MedImmune, Aurinia Pharmaceuticals, Biogen Idec, Bristol Myers Squibb, Calliditas Therapeutics …
Prelude Therapeutics Announces Strategic Business Update 04 Nov 2025 12:05 GMT
… successful tenures at Incyte Corporation, Biogen Idec and AstraZeneca. The Company will …
Cipla receives final approval for generic version of Biogen IDEC Inc.'s Tecfidera (Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter Pack) 28 Sep 2020 20:25 GMT
… generic therapeutic equivalent version of Biogen IDEC Inc.'s Tecfidera®. It … -approval-for-generic-version-of-biogen-idec-incs-tecfidera-dimethyl-fumarate-dr …
Cipla receives final approval for generic version of Biogen IDEC Inc.'s Tecfidera® 25 Sep 2020 04:52 GMT
… generic therapeutic equivalent version of Biogen IDEC Inc.'s Tecfidera®. It …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS